Designing an efficient platform is crucial for any industrial process. This design process is known as process development, and it has become increasingly important in the pharmaceutical industry at ...
In 2022, the combined research and development (R&D) expenditure of the U.S. pharmaceutical industry consisted of more than $100 billion. While this is a significantly expansive market, approximately ...
Developing high-quality, safe, and effective drugs is a complex process that requires varied scientific skills and stringent regulatory assessments. Drug development is a process that spans many years ...
Explore how proteomics transforms pharmaceutical R&D, from drug discovery to biomarker qualification and clinical development ...
As sponsors advanced more niche and personalized modalities, manufacturers were pushed to adopt holistic approaches to safety ...
GlobalData on MSN
Teijin and Aska Pharmaceutical to co-develop gynaecological drugs
The collaboration intends to improve compound screening by employing CADD and AI technologies.
In Silicon Valley, scientific altruism meets entrepreneurship in the race for ne A research team has reason to celebrate after the Food and Drug Administration granted it approval on Friday to begin a ...
Overview Artificial intelligence seems to be transforming drug discovery in 2026, enabling faster molecule design, smarter clinical trials, and reduced R&D ...
Hosted on MSN
AlphaFold opens new doors in drug development—how
AlphaFold, a transformative AI-driven tool developed by DeepMind, has revolutionized the field of structural biology by accurately predicting protein structures. This breakthrough holds significant ...
InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a pharmaceutical company focused on developing a pipeline of disease-modifying ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results